Windtree Therapeutics Inc (WINT)

[INV4]

Total Shares Outstanding (millions) = 12

https://www.nasdaq.com/market-activity/stocks/wint/institutional-holdings

=============================

Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure

July 12, 2025

1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old

If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039

WARRINGTON, Pa., July 02, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a diversified company focused on revenue generation in multiple growing industries is pleased to announce that the United States Patent and Trademark Office has issued an istaroxime patent for the United States - application number 18/150,870 directed to “ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE.”

About Windtree Therapeutics, Inc.Windtree Therapeutics, Inc. is a diversified company focused on becoming a revenue generating company in a multitude of growing industries to drive toward overall profitability.

https://www.nasdaq.com/press-release/windtree-announces-issuance-istaroxime-patent-united-states-acute-heart-failure-2025

$WINT